News: Portfolio 2005

Ventaira Contact:

Leslie J. Williams

(614)340-2338

 

FOR IMMEDIATE RELEASE

VENTAIRA PHARMACEUTICALS ANNOUNCES $13.5M PRIVATE EQUITY FINANCING

COLUMBUS, Ohio – March 30, 2005 – Ventaira Pharmaceuticals, a privately-held specialty pharmaceutical company, today announced that it has completed a private placement of Series C Preferred Stock totaling $13.5 million. Ventaira is focused on the development of a best-in-class next generation inhalation device using its novel proprietary electrohydrodynamic (EHD) aerosolization and formulation platforms.